Nadja Rozovsky

Nadja Rozovsky is a seasoned professional with extensive experience in program management and market insights within the pharmaceutical industry. Currently serving as Associate Director of Program Management and Director of Global Insights & Analytics at Alnylam Pharmaceuticals, Nadja leads market research initiatives focused on ATTR amyloidosis for both U.S. and global launch products. Previously, as Associate Director of US & Global Market Insights at Takeda, Nadja collaborated with development teams and business development assessments, providing critical market research and competitive intelligence for pipeline assets in neurology, psychiatry, and rare diseases. Nadja's earlier roles include Director of Niche Markets and Rare Diseases at Decision Resources, where contributions to the niche and rare disease portfolio were significant, as well as various analytical roles focusing on CNS and ophthalmology. Nadja holds a Ph.D. in Biochemistry from Brandeis University, and a Master's degree in Plant Sciences and Bachelor's degree in Biology from The Hebrew University of Jerusalem.